CDKL5's role in microtubule-based transport and cognitive function
André T. LopesiD, Ondine Janiv, Suzanne ClaxtoniD, Sila K. UltaniriD
Abstract
Cyclin-dependent kinase like 5 (CDKL5) is a serine-threonine kinase highly enriched in mammalian neurons. CDKL5 is located on the X-chromosome and its loss-of-function leads to a severe neurodevelopmental disorder called CDKL5 deficiency disorder (CDD). CDKL5 phosphorylates microtubule-associated protein MAP1S and regulates its binding to microtubules. How MAP1S phosphorylation affects microtubule function is not well understood. To address this question, we generated MAP1S phosphomutant mice, in which the CDKL5 phosphorylation sites S786 and S812 are mutated to Alanine (MAP1S S786/812A or MAP1S SA). Using a microtubule co-sedimentation assay, we showed that dynein binding to microtubules is severely reduced in CDKL5 knockout (KO) and MAP1S SA brains. Time-lapse imaging in primary neurons showed impaired dynein motility in both Cdkl5 KO and MAP1S SA. Dynein-driven cargo transport was affected in mutant neuron dendrites, including the delivery of -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. We next studied tubulin tyrosination in Cdkl5 KO and MAP1S SA neurons and found that both mutants had a reduced tubulin tyrosination when compared to WT neurons. Since dynein-dynactin has a higher affinity for tyrosinated microtubules, we hypothesized that reduced tyrosination in MAP1S phosphomutant mice could be the mechanistic cause of impaired dynein motility. In support of this, we show that upon expression of tubulin tyrosine kinase TTL, we rescued dynein motility defects in MAP1S phosphomutant neurons. Hippocampal neurons derived from MAP1S SA mice revealed a significant reduction in spine density and synapses, and altered spine morphology. Finally, behavioral phenotyping of MAP1S phosphomutant mice showed increased anxiety, impaired motor performance, social and memory deficits, mirroring to some extent the clinical manifestations present in CDD patients. Our results reveal MAP1S phosphorylation to be an important contributor to dynein-mediated transport and synapse formation. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=78 SRC="FIGDIR/small/610038v1_ufig1.gif" ALT="Figure 1"> View larger version (17K): org.highwire.dtl.DTLVardef@12e50a2org.highwire.dtl.DTLVardef@1aff4b4org.highwire.dtl.DTLVardef@ea7b37org.highwire.dtl.DTLVardef@3f7826_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cyclin-dependent kinase-like 5 (CDKL5) binds to talin and is anchored at the postsynaptic density via direct interaction with PDZ domains
Y Otani, Emily Goodall, … Benjamin Thomas Goult·bioRxiv·Aug 27, 2025
- Epilepsy-related CDKL5 deficiency slows synaptic vesicle endocytosis in central nerve terminals
Christiana Kontaxi, Daniela Ivanova, … Michael Alan Cousin·Journal of NeurosciencePeer-reviewed·Feb 9, 2023
- mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder.
Antonia Gurgone, Riccardo Pizzo, … Maurizio Giustetto·NeuropsychopharmacologyPeer-reviewed·Aug 9, 2022
- Probing the functions of microglial cyclin-dependent kinase 5 under physiological and pathological conditions
Zhuyu Peng, Wen‐Chin Huang, … Li‐Huei Tsai·bioRxiv·May 12, 2020
- Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology
Anna M. Castano, Margaux Silvestre, … Alison Donnelly Axtman·eLifePeer-reviewed·Jul 25, 2023
- Enhanced hippocampal LTP but typical NMDA receptor and AMPA receptor function in a novel rat model of CDKL5 deficiency disorder
Laura Simões de Oliveira, Heather O’Leary, … Peter C. Kind·bioRxiv·Jun 29, 2022